Lawmakers Question Medicare Policy On Anemia Drug Epogen During Congressional Hearing

... Lawmakers might consider revisions to the Medicare reimbursement policy for anemia medications used in the treatment of kidney dialysis patients, after experts at a House Ways and Means Committee hearing on Wednesday testified that the policy encourages "overuse that is wasteful, costly and raises the risk of heart complications," Reuters/New York Times reports. [click link for full article] ...